Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan-Reference-Cited by-同舟云学术

Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan

Published:2023-10-23 Issue:20 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Liu Yanyan^ORCID,Chen Tingting^ORCID,Zhu Yongqi^ORCID,Furey Aisha^ORCID,Lowary Todd L.,Chan John,Bournazos Stylianos^ORCID,Ravetch Jeffrey V.,Achkar Jacqueline M.^ORCID

Funder

National Institute of Health (NIH)/National Institute of Allergy and Infectious Diseases

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/167960/files/pdf

Reference72 articles.

1. World Health Organization. Global Tuberculosis Report 2022. https://www.who.int/publications/i/item/9789240061729 Published October 27, 2022. Accessed September 28, 2023

2. Immune evasion and provocation by Mycobacterium tuberculosis

3. The knowns and unknowns of latent Mycobacterium tuberculosis infection

4. World Health Organization. Global Tuberculosis Report 2021. https://www.who.int/publications/i/item/9789240037021 Published October 14, 2021. Accessed September 28, 2023

5. Therapeutic Vaccines for Tuberculosis: An Overview

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen specificity shapes antibody functions in tuberculosis;2024-06-04

2. Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates;eBioMedicine;2024-01

3. Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID/WGNV workshop report 2023;Frontiers in Tuberculosis;2023-11-15